Add like
Add dislike
Add to saved papers

Concentration-dependent cytokine responses of silica nanoparticles and role of ROS in human lung epithelial cells.

Reactive oxygen species (ROS) is regarded as a critical denominator in nanoparticle toxicology and inflammation. Previously, we have shown that silica nanoparticles sized 50 nm (Si50) induce release of CXCL8 and IL-6 from BEAS-2B cells, via mechanisms involving NFκB, p38 MAPkinase, and TGF-α-activated EGF-receptor. In the present study, the role of ROS-mediated mechanisms in the concentration-dependent Si50-induction of CXCL8 and IL-6 responses was examined. Si50 (200 μg/ml) induced a time-dependent ROS formation, and a postponed increase in expression of heme oxygenase (HO-1) mRNA and protein. Pre-treatment with the ROS-inhibitors N-acetyl cysteine (NAC) and diphenyleneiodonium (DPI) partially attenuated CXCL8 and IL-6 responses to 200 μg/ml, but not to 100 μg/ml Si50. The release of TGF-α induced by Si50 (200 μg/ml) was significantly reduced by NAC, but not by DPI and siRNA against NADPH-oxidase DUOX-1 (siDUOX-1). Furthermore, siDUOX-1 reduced Si50-induced CXCL8, but not IL-6. Both p38- and p65-phosphorylations were inhibited by siDUOX-1, but for NAC only p65-phosphorylation reached a significant reduction. Neither NAC nor DPI reduced Si50-induced CXCL8 and IL-6 gene expressions. In conclusion, Si50 -induced CXCL8 and IL-6 involved both ROS-dependent and -independent mechanisms. Notably, the role of ROS seemed restricted to effects of higher concentrations of Si50 and not mediated via the gene expression. This article is protected by copyright. All rights reserved.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app